Publications
Select an author
Search
2016
- NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cells.
Jayavelu AK, Müller JP, Bauer R, Böhmer SA, Lässig J, Cerny-Reiterer S, Sperr WR, Valent P, Maurer B, Moriggl R, Schröder K, Shah AM, Fischer M, Scholl S, Barth J, Oellerich T, Berg T, Serve H, Frey S, Fischer T, Heidel FH, Böhmer FD
Leukemia 2016, 30(2), 473-83 - Characteristics and treatment of polycythemia vera patients in clinical practice: a multicenter chart review on 1476 individuals in Germany.
Jentsch-Ullrich K, Eberhardt J, Zeremski V, Koehler M, Wolleschak D, Heidel FH
J Cancer Res Clin Oncol 2016, 142(9), 2041-9 - Kinomics Screening Identifies Aberrant Phosphorylation of CDC25C in FLT3-ITD-positive AML.
Perner F, Schnöder TM, Fischer T, Heidel FH
Anticancer Res 2016, 36(12), 6249-58 - Specificity of JAK-kinase inhibition determines impact on human and murine T-cell function.
Perner F, Schnöder TM, Ranjan S, Wolleschak D, Ebert C, Pils MC, Frey S, Polanetzki A, Fahldieck C, Schönborn U, Schraven B, Isermann B, Fischer T, Heidel FH
Leukemia 2016, 30(4), 991-5 - Leukemic mastopathy.
Schalk E, Heidel FH
Int J Hematol 2016, 103(4), 357-8 - Palbociclib treatment of FLT3-ITD+ AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6.
Uras IZ, Walter GJ, Scheicher R, Bellutti F, Prchal-Murphy M, Tigan AS, Valent P, Heidel FH, Kubicek S, Scholl C, Fröhling S, Sexl V
Blood 2016, 127(23), 2890-902 - Chronic myelogenous leukemia evolving after treatment of multiple myeloma.
Wolleschak D, Heidel FH
Blood 2016, 128(1), 146 - lncRNA-Induced Nucleosome Repositioning Reinforces Transcriptional Repression of rRNA Genes upon Hypotonic Stress.
Zhao Z, Dammert MA, Grummt I, Bierhoff H
Cell Rep 2016, 14(8), 1876-82 - Heat shock represses rRNA synthesis by inactivation of TIF-IA and lncRNA-dependent changes in nucleosome positioning.
Zhao Z, Dammert MA, Hoppe S, Bierhoff H, Grummt I
Nucleic Acids Res 2016, 44(17), 8144-52
